Skip to main content

Advertisement

SpringerLink
Log in

Decompensated cirrhosis and microbiome interpretation

  • Brief Communications Arising
  • Published:

From Nature

View current issue Submit your manuscript

A Brief Communications Arising to this article was published on 16 September 2015

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Microbiota distribution between compensated and decompensated cirrhotic subjects.

References

  1. Schuppan, D. & Afdhal, N. H. Liver cirrhosis. Lancet 371, 838–851 (2008)

    Article  CAS  Google Scholar 

  2. Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59–64 (2014)

    Article  ADS  CAS  Google Scholar 

  3. Bajaj, J. S. et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G168–G175 (2012)

    Article  CAS  Google Scholar 

  4. Chen, Y. et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562–572 (2011)

    Article  Google Scholar 

  5. Bajaj, J. S. et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G675–G685 (2012)

    Article  CAS  Google Scholar 

  6. Chavez-Tapia, N. C., Tellez-Avila, F. I., Garcia-Leiva, J. & Valdovinos, M. A. Use and overuse of proton pump inhibitors in cirrhotic patients. Med. Sci. Monit. 14, CR468–CR472 (2008)

    PubMed  Google Scholar 

  7. Bajaj, J. S. et al. A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metab. Brain Dis. 27, 205–215 (2012)

    Article  CAS  Google Scholar 

  8. Bajaj, J. S. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J. Hepatol. 60, 940–947 (2014)

    Article  CAS  Google Scholar 

  9. Bajaj, J. S. et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS ONE 8, e60042 (2013)

    Article  ADS  CAS  Google Scholar 

  10. Kanno, T. et al. Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem. Biophys. Res. Commun. 381, 666–670 (2009)

    Article  CAS  Google Scholar 

  11. Bajaj, J. S. et al. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function. Am. J. Physiol. Gastrointest. Liver Physiol. 307, G951–G957 (2014)

    Article  CAS  Google Scholar 

  12. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011)

    Article  Google Scholar 

  13. Gillevet, P., Sikaroodi, M., Keshavarzian, A. & Mutlu, E. A. Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem. Biodivers. 7, 1065–1075 (2010)

    Article  CAS  Google Scholar 

  14. Zhang, Z. et al. Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing. Am. J. Gastroenterol. 108, 1601–1611 (2013)

    Article  ADS  CAS  Google Scholar 

  15. Elkrief, L. et al. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology 60, 823–831 (2014)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, 23249, Virginia, USA

    Jasmohan S. Bajaj

  2. Microbiome Analysis Center, George Mason University, Manassas, 20110, Virginia, USA

    Naga S. Betrapally & Patrick M. Gillevet

Authors
  1. Jasmohan S. Bajaj
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naga S. Betrapally
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick M. Gillevet
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J.S.B. supervised the patient recruitment, sample collection and clinical analysis. He was also involved in the data interpretation, analysis and drafting of the manuscript. N.S.B. was involved in data analysis and interpretation. P.M.G. was responsible for data analysis, interpretation and drafting of the manuscript. All authors participated in the critical revision of the manuscript.

Corresponding author

Correspondence to Jasmohan S. Bajaj.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bajaj, J., Betrapally, N. & Gillevet, P. Decompensated cirrhosis and microbiome interpretation. Nature 525, E1–E2 (2015). https://doi.org/10.1038/nature14851

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature14851

  • Springer Nature Limited

This article is cited by

Search

Navigation